Skip to main content
TipRanks
Go Ultimate75% OFF

Editas Medicine (EDIT) Financial Statements

3,595 Followers

Editas Medicine Financial Overview

Editas Medicine's market cap is currently $394.70M. The company's EPS TTM is $-0.62; its P/E ratio is -4.45; Editas Medicine has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 40.52M$ 32.31M$ 78.12M$ 19.71M$ 25.54M
Gross Profit$ 40.52M$ -166.93M$ 72.06M$ 13.38M$ 20.49M
Operating Income$ -99.34M$ -251.15M$ -169.18M$ -225.95M$ -193.15M
EBITDA$ -148.61M$ -233.11M$ -147.16M$ -214.09M$ -187.45M
Net Income$ -160.06M$ -237.09M$ -153.22M$ -220.43M$ -192.50M
Balance Sheet
Cash & Short-Term Investments$ 146.65M$ 269.91M$ 323.11M$ 344.27M$ 499.85M
Total Assets$ 186.53M$ 341.59M$ 499.15M$ 514.32M$ 677.48M
Total Debt$ 76.71M$ 35.03M$ 48.54M$ 43.95M$ 26.38M
Net Debt$ -69.94M$ -96.51M$ -75.11M$ -97.58M$ -177.14M
Total Liabilities$ 159.25M$ 207.31M$ 150.06M$ 153.64M$ 123.84M
Stockholders' Equity$ 27.29M$ 134.27M$ 349.10M$ 360.68M$ 553.64M
Cash Flow
Free Cash Flow$ -165.85M$ -219.11M$ -136.90M$ -181.47M$ -171.78M
Operating Cash Flow$ -165.24M$ -210.28M$ -132.18M$ -177.35M$ -163.80M
Investing Cash Flow$ 138.67M$ 162.15M$ -3.73M$ 114.07M$ -54.47M
Financing Cash Flow$ 40.47M$ 56.03M$ 118.04M$ 1.28M$ 282.11M

Currency in USD

Editas Medicine Earnings and Revenue History

-300M-150M0150M-1200 %-800 %-400 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Editas Medicine Liabilities to Assets

0250M500M750M0 %30 %60 %90 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Editas Medicine Cash Flow

-300M-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing

Editas Medicine Forecast EPS vs Actual EPS

-0.3-0.3-0.2-0.2-0.1-0.100Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss